Cardiovascular Systems Inc Quarterly Income Tax Expense (Benefit) in USD from Q3 2015 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Cardiovascular Systems Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2015 to Q4 2022.
  • Cardiovascular Systems Inc Income Tax Expense (Benefit) for the quarter ending December 31, 2022 was $49K, a 22.2% decline year-over-year.
  • Cardiovascular Systems Inc Income Tax Expense (Benefit) for the twelve months ending December 31, 2022 was $141K, a 56.6% decline year-over-year.
  • Cardiovascular Systems Inc annual Income Tax Expense (Benefit) for 2022 was $310K, a 23% increase from 2021.
  • Cardiovascular Systems Inc annual Income Tax Expense (Benefit) for 2021 was $252K, a 9.09% increase from 2020.
  • Cardiovascular Systems Inc annual Income Tax Expense (Benefit) for 2020 was $231K, a 21.6% increase from 2019.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $141K $49K -$14K -22.2% Oct 1, 2022 Dec 31, 2022 10-Q 2023-02-09
Q3 2022 $155K -$19K -$155K -114% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $310K $48K -$15K -23.8% Apr 1, 2022 Jun 30, 2022 10-K 2022-08-18
Q1 2022 $325K $63K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $325K $63K $0 0% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-09
Q3 2021 $325K $136K +$73K +116% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $252K $63K -$39K -38.2% Apr 1, 2021 Jun 30, 2021 10-K 2022-08-18
Q1 2021 $291K $63K +$16K +34% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $275K $63K +$19K +43.2% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-03
Q3 2020 $256K $63K +$25K +65.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $231K $102K +$64K +168% Apr 1, 2020 Jun 30, 2020 10-K 2022-08-18
Q1 2020 $167K $47K -$39K -45.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $206K $44K +$11K +33.3% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-04
Q3 2019 $195K $38K +$5K +15.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $190K $38K +$5K +15.2% Apr 1, 2019 Jun 30, 2019 10-K 2021-08-19
Q1 2019 $185K $86K +$53K +161% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $132K $33K $0 0% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-06
Q3 2018 $132K $33K $0 0% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $132K $33K +$13K +65% Apr 1, 2018 Jun 30, 2018 10-K 2020-08-20
Q1 2018 $119K $33K +$15K +83.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-03
Q4 2017 $104K $33K +$9K +37.5% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-01
Q3 2017 $95K $33K +$9K +37.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-02
Q2 2017 $86K $20K -$15K -42.9% Apr 1, 2017 Jun 30, 2017 10-K 2019-08-23
Q1 2017 $101K $18K +$7K +63.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 $94K $24K +$1K +4.35% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-09
Q3 2016 $93K $24K +$1K +4.35% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 $92K $35K Apr 1, 2016 Jun 30, 2016 10-K 2018-08-23
Q1 2016 $11K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 $23K Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-03
Q3 2015 $23K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.